Home -> Law Blog Directory -> Personal Injury Law Blogs -> P.I.S.S.D. -- Personal Injury, Social Security Disability
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: P.I.S.S.D. -- Personal Injury, Social Security DisabilityStudy Finds That Consumers Overlook Over-The-Counter Drug Warnings
By Robert Kraft
Bloomberg News reported, "Consumers overlook warnings about potential tampering on over-the-counter medications at least 80 percent of the time, suggesting packages and labels need to be redesigned to attract attention and improve safety, a study found." The study's "participants spent the most time focused on the brand names and product claims of nonprescription drugs" and "more than half of those surveyed also missed alerts about child safety on medicines that did not have child-resistant packaging, according to the research today in the Proceedings of the National Academy of Sciences." The results of the study "raise doubts about whether the warnings meet U.S. Food and Drug Administration requirements that they be 'prominent' and 'conspicuous,' the researchers said."
From the American Association for Justice news release.
Full post as published by P.I.S.S.D. -- Personal Injury, Social Security Disability on March 31, 2009 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...
Bank Website Security
New Report Finds Widespread Flaws
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Acetaminophen
FDA Wants New Safety Warnings
CellCept
Roche Issues Changes to Warnings and Adverse Events
Darvon
Other Propoxyphene-Containing Meds to Require Stronger Warnings

Study Finds That Consumers Overlook Over-The-Counter Drug Warnings
Consumer Union wants FDA to strengthen medical device warnings in ads
NJ sepnds $331 million a year incarcerating people with non-violent drug offenses
New study urging drug sentencing alternatives in New Jersey to save $$$
Food and Drug Administration to Strengthen Warnings for Antidepressant Drugs








